Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) — Capital Reinvestment Ratio
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has a Capital Reinvestment Ratio of 0.95x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥45.11 Million) in capital expenditures (CN¥42.81 Million). Check Shandong Bailong Chuangyuan Bio-Tech Co. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Capital Reinvestment Ratio (2016–2025)
This chart tracks Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see 605016 cash generation efficiency.
Annual Capital Reinvestment Ratio for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025. See Shandong Bailong Chuangyuan Bio-Tech Co. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.19x | CN¥135.45 Million | CN¥296.80 Million | ▲ +134.0% |
| 2024 | 0.94x | CN¥300.89 Million | CN¥281.81 Million | ▼ -41.6% |
| 2023 | 1.60x | CN¥194.63 Million | CN¥311.98 Million | ▲ +36.8% |
| 2022 | 1.17x | CN¥149.82 Million | CN¥175.60 Million | ▲ +102.0% |
| 2021 | 0.58x | CN¥96.20 Million | CN¥55.82 Million | ▲ +20.5% |
| 2020 | 0.48x | CN¥121.82 Million | CN¥58.66 Million | ▼ -45.4% |
| 2019 | 0.88x | CN¥64.08 Million | CN¥56.49 Million | ▼ -10.8% |
| 2018 | 0.99x | CN¥89.12 Million | CN¥88.11 Million | ▲ +206.0% |
| 2017 | 0.32x | CN¥113.47 Million | CN¥36.66 Million | ▼ -30.8% |
| 2016 | 0.47x | CN¥60.10 Million | CN¥28.08 Million | — |